Comparative survival analysis of liver resection (LR), percutaneous radiofrequency ablation (PRFA), and transarterial chemoembolization (TACE) in early multinodular hepatocellular carcinoma (HCC) patients reveals LR as the preferred therapeutic option for improved survival rates at 1, 3, and 5 years. LR demonstrates superior outcomes compared to PRFA and TACE, highlighting the importance of considering LR as the primary treatment choice for eligible patients with early multinodular HCC.
Journal Article by Vitale A, Romano P (…) De Carlis L et 81 al. in JAMA Surg